Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma

HPB

Volumn 11, Issue 4, 2009, Pages 311-320

  Ng, Keh M ^a   Yan, Tristan D ^a   Black, Deborah ^b   Chu, Francis C K ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Large hepatocellular; Resection and ablation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOABLATION; DEMOGRAPHY; DISEASE FREE SURVIVAL; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; HYPOVOLEMIC SHOCK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGY; PROGNOSIS; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SEPSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR THROMBUS; TUMOR VOLUME; VASCULAR TUMOR;

EID: 70349180908     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00044.x     Document Type: Article

References (48)

1. Poon RTP, Fan ST, Wong J. (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592-602.
2. Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P et al. (1997) Prospective randomized trial of chemoembolization versus intra-arterial injection of I-labelled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 26:1156-1161.
3. Lau WY, Leung TWT, Yu SCH, Ho SKW. (2003) Percutaneous local ablative therapy for hepatocellular carcinoma. A review and look into the future. Ann Surg 237:171-179.
4. Lai ECS, Ng IOL, You KT, Fan ST, Mok FPT, Tan ESY et al. (1991) Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience. World J Surg 15:654-659.
5. Chu F, Morris DL. (2006) Single centre experience of liver resection for hepatocellular carcinoma in patients outside transplant criteria. Eur J Surg Oncol 32:568-572.
6. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J et al. (2004) Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12:1-10.
7. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N et al. (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20:1527-1536.
8. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218:145-151.
9. Penn I. (1991) Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 100:726-735.
10. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Takayama T et al. (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198-1206.
11. Lee NH, Chau GY, Lui WY, King KL, Tsay SH, Wu CW. (1998) Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg 85:1654-1657.
12. Abdel-Wahab M, Sultan A, El-Ghawalby A, Fathy O, El-Ebidy G, Abo-Zeid M et al. (2001) Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases. Hepatogastroenterology 48:757-761.
13. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N et al. (2002) Hepatic resection for hepatocellular carcinoma in diameter of = 10 cm. Hepatogastroenterology 49:518-523.
14. Yeh CN, Lee WC, Chen MF. (2002) Hepatic resection and prognosis for patients with hepatocellular carcinoma large than 10 cm: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 10:1070-1076.
15. Zhou XD, Tang ZY, Ma ZC, Wu ZQ, Fan J, Qin LX et al. (2003) Surgery for large primary liver cancer more than 10 cm in diameter. J Cancer Res Clin Oncol 129:543-548.
16. Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH et al. (2003) Multimodality management of hepatocellular carcinoma larger than 10 cm. Am Coll Surg 197:730-738.
17. Chen XP, Qiu FZ, Wu ZD, Zhang BX. (2004) Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg 91:322-326.
18. Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR et al. (2005) Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 104:1948-1955.
19. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA et al. (2005) Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450-458.
20. Nagano Y, Tanaka K, Togo S, Matsuo K, Kunisaki C, Sugita M et al. (2005) Efficacy of hepatic resection for hepatocellular carcinoma larger than 10 cm. World J Surg 29:66-71.
21. Chen XP, Qiu FZ, Qu ZD, Zhang BX. (2006) Hepatectomy for huge hepatocellular carcinoma in 634 cases. World J Gastroenterol 12:4652-4655.
22. Shah SA, Wei AC, Cleary SP, Yang H, McGilvray ID, Gallinger S et al. (2007) Prognosis and results after resection of very large (=10 cm) hepatocellular carcinoma. J Gastrointest Surg 11:589-595.
23. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. (2007) Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 14:2817-2823.
24. Zhou L, Rui JA, Wang SH, Chen SG, Qu Q, Chi TY et al. (2007) Outcomes and prognostic factors for cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 31:1782-1787.
25. Grazi GL, Ercolani G, Pierangeli F, Gaudio MD, Cescon M, Cavallari A et al. (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhocic give the procedure added value. Ann Surg 234:71-78.
26. Yeh CN, Chen MF, Lee WC, Jeng LB. (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81:195-202.
27. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugwara Y et al. (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients. Is there a way? A prospective analysis of our approach. Arch Surg 134:984-992.
28. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC et al. (2000) Clinical significance of microscopic tumour venous invasion in patients with respectable hepatocellular carcinoma. Surgery 127:603-608.
29. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IOL, Yamaoka Y et al. (2005) Tumour size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma liver. Transplantation 11:1086-1092.
30. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IOL, Yamaoka Y et al. (2005) Tumour size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma liver. Transplantation 11:1086-1092.
31. Chin PL, Chu DZJ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD. (1999) Ethnic differences in the behaviour of hepatocellular carcinoma. Cancer 85:1931-1936.
32. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. (2004) Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol 11:298-303.
33. Okuda K. (2002) Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 17:401-405.
34. Nagorney DM, Adson MA, Weiland LH, Knight CD, Jr, Smalley SR, Zinsmeister AR. (1985) Fibrolamellar hepatoma. Am J Surg 149:113-119.
35. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doberty D, Ikai I et al. (2002) Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 6:224-232.
36. Oishi K, Itamoto T, Amano H, Fukuda S, Ohdan H, Tashiro H et al. (2007) Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol 95:311-316.
37. Ogawa S, Kumara T, Toyoda H, Ichikawa H, Kawachi T, Otobe K et al. (2006) Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur J Radiol 59:74-81.
38. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J et al. (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentgenol 172:969-976.
39. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. (2000) Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 25:246-250.
40. Lai ECH, Lau WY. (2006) Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg 141:191-198.
41. Lai ECS, Ng IOL, You KT, Choi TK, Fan ST, Mok FPT et al. (1991) Hepatectomy for large hepatocellular carcinoma: the optimal resection margin. World J Surg 15:141-145.
42. Hou RM, Chu F, Zhao J, Morris DL. (2007) The effects of surgical margin and edge cryotherapy after liver resection for colorectal cancer metastases. HPB 9:201-207.
43. Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, Ikeda T et al. (1995) Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 169:400-405.
44. Izumi R, Shimizu K, Iyobe T, Ii T, Yagi M, Matsui O et al. (1994) Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 20:295-301.
45. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J et al. (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 356:802-807.
46. Lo CM, Liu CL, Chan SC, Lam CM, Poon RT, Ng IO et al. (2007) A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 245:837-842.
47. Lau WY, Lai ECH, Leung TWT, Yu SCH. (2008) Adjuvant intra-arterial iodine-131-labeled lipiodol for respectable hepatocellular carcinoma: a prospective randomized trial - upate on 5-year and 10-year survival. Ann Surg 247:43-48.
48. Gautam AM, Wilson EA, Chen PJ, Lee PH, Lin DY, Wu CC et al. A novel heparanase inhibitor, as adjuvant therapy for hepatocellular carcinoma: a large randomized phase II clinical trial. Proc AACR Ann Meet 2007; 232:2650.